InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
71.25
(
0.50%
)
Bitcoin
90,919.54
(
-0.15%
)
Post# of 253623
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: ghmm post# 154403

Wednesday, 12/19/2012 5:06:12 PM

Wednesday, December 19, 2012 5:06:12 PM

Post# of 253623
FOLD -50% a/h.. Amicus Therapeutics (FOLD) and GlaxoSmithKline (GSK) announce results from the Phase III study of its investigational oral migalastat HCl monotherapy in patients with Fabry disease, noting the pre-designated primary endpoint was not achieved. FOLD -50%, GSK -0.7% AH
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up